Long-term outcomes of a shortened triple-drug regimen for acute promyelocytic leukemia: A 5-year real-world, single-center experience

Cancer Treatment and Research Communications · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles